GlobeNewswire by notified

Anmodning om ophør af suspension

Del

Idet de tekniske vanskeligheder hos ekstern leverandør nu er løst, kan der igen beregnes indre værdier.

Der anmodes derfor om ophør af suspension i samtlige investeringsforeninger under Invest Administration A/S:

  • Investeringsforeningen Carnegie Wealth Management
  • Investeringsforeningen Falcon Invest
  • InvesteringsforeningenFundamental Invest
  • InvesteringsforeningenGudme Raaschou
  • InvesteringsforeningenGreat Dane
  • InvesteringsforeningenIA Invest
  • InvesteringsforeningenLån & Spar Invest
  • InvesteringsforeningenSelected Investments
  • Investeringsforeningen StockRate Invest
  • Investeringsforeningen Advice Capital

Eventuelle henvendelser vedrørende denne meddelelse kan rettes til undertegnede på telefon 3814 6600.

Med venlig hilsen
Invest Administration A/S

Niels Erik Eberhard
Direktør

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

Adevinta ASA (ADE) - Adevinta reports strong Q1 financial performance in soft macro environment28.5.2024 22:37:40 CEST | Press release

Strong EU51 revenue growth: +12% year-on-yearTotal revenues at €480m, up 11%2 year-on-yearTotal EBITDA of €165m, up 14% year-on-year and EBITDA margin of 34.4%Strong cash flow generation and continued deleveraging Oslo, 28 May 2024 - Adevinta ASA (ADE) (“Adevinta'' or “the Company”) reported strong group revenue growth of 11% in the first quarter of 2024 compared to the same period last year. This excludes the impact of the Hungarian business divestment in Q3 2023. EU5 Markets revenues reached €449 million in the quarter, representing a strong 12% growth, despite the soft macroeconomic environment: Online classifieds revenues improved by 16%, supported by continued strong double-digit revenue growth in Mobility, driven by strong double-digit performance in all markets. Real Estate posted a solid performance in the period, driven by Kleinanzeigen and France. Jobs’ performance was back to growth;Transactional revenues grew by 31% year-on-year, with strong revenue growth in all markets;Ad

Information on the Total Number of Voting Rights and Shares28.5.2024 22:30:00 CEST | Press release

REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), May 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA(Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,851,253.43 Total number of securities carrying voting rights: 34,060,390 (all ordinary shares) Total number of voting rights (= denominator): 34,060,390 (all relating to ordinary shares) Number of rights to subscribe to securities carrying voting rights not yet issued: 100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares); 400,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 400,500 securities carrying voting rights (all ordina

Merus N.V. Announces Proposed Public Offering of Common Shares28.5.2024 22:01:00 CEST | Press release

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares (the “Offer Shares”). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the Offer Shares (the “Option Shares” and together with the Offer Shares, the “Shares”). The offering is subject to market conditions and other closing conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Merus currently intends to use the net proceeds from the offering, together with its existing cash, cash equivalents and marketable securiti

HiddenA line styled icon from Orion Icon Library.Eye